How Many Option Care Health, Inc. (NASDAQ:BIOS)’s Analysts Are Bearish?

Option Care Health, Inc. (NASDAQ:BIOS) Logo
Investors sentiment increased to 1.02 in 2019 Q2. Its up 0.02, from 1 in 2019Q1. It increased, as 14 investors sold Option Care Health, Inc. shares while 29 reduced holdings. 16 funds opened positions while 28 raised stakes. 96.75 million shares or 0.75% less from 97.49 million shares in 2019Q1 were reported.
Roanoke Asset Mngmt Corp New York holds 0.54% or 463,780 shares. Perkins Mgmt Inc holds 0.38% or 206,000 shares in its portfolio. Teton Advsrs holds 0.09% or 361,600 shares in its portfolio. California State Teachers Retirement Sys reported 0% of its portfolio in Option Care Health, Inc. (NASDAQ:BIOS). Parametric Port Assoc Lc reported 86,835 shares. Moreover, Marathon Capital Management has 0.05% invested in Option Care Health, Inc. (NASDAQ:BIOS). Grp owns 78,327 shares. Financial Architects holds 500 shares. Proshare Advsrs Limited Liability Company owns 13,413 shares. Barclays Public Limited Company has 0% invested in Option Care Health, Inc. (NASDAQ:BIOS). Gamco Investors Et Al invested in 558,341 shares. Moreover, White Pine Cap Lc has 0.18% invested in Option Care Health, Inc. (NASDAQ:BIOS). Goldman Sachs Grp invested 0% of its portfolio in Option Care Health, Inc. (NASDAQ:BIOS). Citadel Ltd Liability Corporation has invested 0% in Option Care Health, Inc. (NASDAQ:BIOS). Sei Invs Co accumulated 749,696 shares.

Option Care Health, Inc. (NASDAQ:BIOS) Ratings Coverage

Among 3 analysts covering BioScrip (NASDAQ:BIOS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioScrip has $4 highest and $3.5 lowest target. $3.83’s average target is 8.50% above currents $3.53 stock price. BioScrip had 6 analyst reports since March 18, 2019 according to SRatingsIntel. Canaccord Genuity maintained Option Care Health, Inc. (NASDAQ:BIOS) on Monday, March 18 with “Buy” rating. Canaccord Genuity maintained Option Care Health, Inc. (NASDAQ:BIOS) rating on Thursday, August 8. Canaccord Genuity has “Buy” rating and $400 target. Barrington maintained the shares of BIOS in report on Monday, March 18 with “Buy” rating. Lake Street maintained it with “Buy” rating and $3.5 target in Monday, March 18 report. Below is a list of Option Care Health, Inc. (NASDAQ:BIOS) latest ratings and price target changes.

08/08/2019 Broker: Canaccord Genuity Rating: Buy Old Target: $3.5000 New Target: $4.0000 Maintain
11/05/2019 Broker: BidaskScore Rating: Hold Upgrade
18/03/2019 Broker: Lake Street Rating: Buy New Target: $3.5 Maintain
18/03/2019 Broker: Canaccord Genuity Rating: Buy New Target: $3.5 Maintain
18/03/2019 Broker: Barrington Rating: Buy New Target: $4 Maintain
18/03/2019 Broker: Stephens Old Rating: Overweight New Rating: Equal-Weight Downgrade

The stock increased 3.52% or $0.12 during the last trading session, reaching $3.53. About 1.85 million shares traded or 90.81% up from the average. Option Care Health, Inc. (NASDAQ:BIOS) has risen 2.17% since September 13, 2018 and is uptrending. It has outperformed by 2.17% the S&P500.

BioScrip, Inc. provides home infusion services in the United States. The company has market cap of $2.48 billion. The firm engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It currently has negative earnings. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care.

More notable recent Option Care Health, Inc. (NASDAQ:BIOS) news were published by: Nasdaq.com which released: “Friday’s ETF Movers: IHF, CQQQ – Nasdaq” on May 17, 2019, also Nasdaq.com with their article: “BioScrip (BIOS) Reports Q2 Loss, Tops Revenue Estimates – Nasdaq” published on July 30, 2019, Nasdaq.com published: “Why BioScrip Stock Popped and Then Dropped Today – Nasdaq” on March 15, 2019. More interesting news about Option Care Health, Inc. (NASDAQ:BIOS) were released by: Profitconfidential.com and their article: “BIOS Stock Breaks Out; Higher Prices Expected as a Result – Profit Confidential” published on December 03, 2018 as well as Globenewswire.com‘s news article titled: “Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care – GlobeNewswire” with publication date: July 22, 2019.

Option Care Health, Inc. (NASDAQ:BIOS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.